Fundz
Free weekly newsletter

Get the free weekly contract digest

The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New new contracts, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Contract Trends

See who's moving and how much in your market

No credit card required Weekly contract digest

Orchestra BioMed Secures $15 Million Investment from Ligand as Part of Strategic Financing Agreement.

May 06, 2026•about 1 month ago

Contract Type

agreement

LondonManufacturingBiotechnologyHealth CareMedicalMedical Device

Description

Orchestra BioMed has announced a strategic financing agreement with Ligand for a $15 million investment. This funding aims to support the commercialization of their innovative medical technologies.

Company Information

Company

Orchestra BioMed Holdings

Location

London, England, United Kingdom

About

Orchestra BioMed Holdings, Inc. is a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships with leading medical device companies. Its lead product candidate is atrioventricular interval modulation (AVIM) therapy for the treatment of hypertension, and it is also developing Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease.

Predictive Intelligence
Strategic

ML-powered predictions for Orchestra BioMed Holdings's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.